Vinod Ravi, MD, MS, MBA

Peer-Reviewed Articles

1. Chan EY, Ali A, Zubair MM, Nguyen DT, Ibarra-Cortez SH, Graviss EA, Shapira OM, Ravi V, MacGillivray TE, Reardon MJ. Primary cardiac sarcomas: Treatment strategies. J Thorac Cardiovasc Surg 166(3):828-838.e2, 2023. e-Pub 2022. PMID: 35219517.
2. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res 29(9):OF1-OF11, 2023. e-Pub 2023. PMID: 37058010.
3. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2022. PMID: 36151848.
4. Chan EY, Ravi V, Ali A, Nguyen DT, Graviss EA, MacGillivray TE, Reardon MJ. Surgical Management of Primary Pulmonary Artery Sarcoma. Semin Thorac Cardiovasc Surg 35(1):53-64, 2023. e-Pub 2021. PMID: 34743005.
5. Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res 29(2):401-409, 2023. e-Pub 2022. PMID: 36288393.
6. Thiebaud JA, Ravi V, Litwin S, Schuetze SM, Movva S, Agulnik M, Kraft AS, Tetzlaff ED, Somaiah N, von Mehren M. OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer 128(19):3516-3522, 2022. e-Pub 2022. PMID: 35942596.
7. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA. Systemic chemotherapies retain anti-tumor activity in desmoid tumors independent of specific mutations in CTNNB1 or APC: A multi-institutional retrospective study. Clin Cancer Res 28(18):4092-4104, 2022. e-Pub 2022. PMID: 35180772.
8. Ravi V, Subramaniam A, Zheng J, Amini B, Trinh VA, Joseph J, Mennel RG, Bishop AJ, Sturgis EM, Goepfert RP, Yalamanchili S, Botello G, Stephen B, Piha-Paul SA, Patel AB, Lazar AJ, Conley AP, Benjamin RS, Patel SR, Futreal PA, Somaiah N, Naing A. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer 128(18):3383-3391, 2022. e-Pub 2022. PMID: 35792683.
9. Somaiah N, Conley AP, Parra ER, Lin H, Amini B, Solis Soto L, Salazar R, Barreto C, Chen H, Gite S, Haymaker C, Nassif EF, Bernatchez C, Mitra A, Livingston JA, Ravi V, Araujo DM, Benjamin R, Patel S, Zarzour MA, Sabir S, Lazar AJ, Wang WL, Daw NC, Zhou X, Roland CL, Cooper ZA, Rodriguez-Canales J, Futreal A, Soria JC, Wistuba II, Hwu P. Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol 23(9):1156-1166, 2022. e-Pub 2022. PMID: 35934010.
10. Chan EY, Ali A, Umana JP, Nguyen DT, Hamilton DJ, Graviss EA, Ravi V, MacGillivray TE, Reardon MJ. Management of primary cardiac paraganglioma. J Thorac Cardiovasc Surg 164(1):158-166.e1, 2022. e-Pub 2020. PMID: 33148444.
11. Subramaniam A, Giani C, Napolitano A, Ravi V, Frezza AM, Jones RL. Management of Vascular Sarcoma. Surg Oncol Clin N Am 31(3):485-510, 2022. PMID: 35715146.
12. Bishop AJ, Zheng J, Subramaniam A, Ghia AJ, Wang C, McGovern SL, Patel S, Guadagnolo BA, Mitra D, Farooqi A, Reardon MJ, Kim B, Guha-Thakurta N, Li J, Ravi V. Cardiac Angiosarcomas: Risk of Brain Metastasis and Hemorrhage Warrants Frequent Surveillance Imaging and Early Intervention. Am J Clin Oncol 45(6):258-263, 2022. e-Pub 2022. PMID: 35588225.
13. Gounder MM, Agaram NP, Trabucco SE, Robinson V, Ferraro RA, Millis SZ, Krishnan A, Lee J, Attia S, Abida W, Drilon A, Chi P, Angelo SP, Dickson MA, Keohan ML, Kelly CM, Agulnik M, Chawla SP, Choy E, Chugh R, Meyer CF, Myer PA, Moore JL, Okimoto RA, Pollock RE, Ravi V, Singh AS, Somaiah N, Wagner AJ, Healey JH, Frampton GM, Venstrom JM, Ross JS, Ladanyi M, Singer S, Brennan MF, Schwartz GK, Lazar AJ, Thomas DM, Maki RG, Tap WD, Ali SM, Jin DX. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nat Commun 13(1):3406, 2022. e-Pub 2022. PMID: 35705558.
14. Jones RL, Ravi V, Brohl AS, Chawla S, Ganjoo KN, Italiano A, Attia S, Burgess MA, Thornton K, Cranmer LD, Cheang MCU, Liu L, Robertson L, Adams B, Theuer C, Maki RG. Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical Trial. JAMA Oncol 8(5):740-747, 2022. e-Pub 2022. PMID: 35357396.
15. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12:1008484, 2022. e-Pub 2022. PMID: 36313661.
16. Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer L, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwiatkowski DJ, Desai NP, Dickson MA. nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors. J Clin Oncol 39(33):JCO2101728, 2021. e-Pub 2021. PMID: 34637337.
17. Parkes A, Wang WL, Patel S, Leung CH, Lin H, Conley AP, Somaiah N, Araujo DM, Zarzour M, Livingston JA, Ludwig J, Roland CL, Ravi V, Benjamin RS, Ratan R. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast. Breast Cancer Res Treat 186(3):871-882, 2021. e-Pub 2021. PMID: 33575859.
18. Frezza AM, Ravi V, Lo Vullo S, Vincenzi B, Tolomeo F, Chen TW, Teterycz P, Baldi GG, Italiano A, Penel N, Brunello A, Duffaud F, Hindi N, Iwata S, Smrke A, Fedenko A, Gelderblom H, Van Der Graaf W, Vozy A, Connolly E, Grassi M, Benjamin RS, Broto JM, Grignani G, Jones RL, Kawai A, Tysarowski A, Mariani L, Casali PG, Stacchiotti S. Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med 10(8):2645-2659, 2021. e-Pub 2021. PMID: 33713582.
19. Wagner MJ, Lyons YA, Siedel JH, Dood R, Nagaraja AS, Haemmerle M, Mangala LS, Chanana P, Lazar AJ, Wang WL, Ravi V, Holland EC, Sood AK. Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep 11(1):9362, 2021. e-Pub 2021. PMID: 33931674.
20. Tsimberidou AM, Hong DS, Fu S, Karp DD, Piha-Paul S, Kies MS, Ravi V, Subbiah V, Patel SM, Tu SM, Janku F, Heymach J, Johnson A, Cartwright C, Zhao L, Zhang J, Berry DA, Vining DJ, Futreal A, Miller VA, Meric-Bernstam F. Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study. NPJ Precis Oncol 5(1):21, 2021. e-Pub 2021. PMID: 33742104.
21. Chan JY, Lim JQ, Yeong J, Ravi V, Guan P, Boot A, Tay TKY, Selvarajan S, Md Nasir ND, Loh JH, Ong CK, Huang D, Tan J, Li Z, Ng CC, Tan TT, Masuzawa M, Sung KW, Farid M, Quek RHH, Tan NC, Teo MCC, Rozen SG, Tan P, Futreal A, Teh BT, Soo KC. Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma. J Clin Invest 130(11):5833-5846, 2020. PMID: 33016928.
22. Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer 8(1), 2020. PMID: 32188704.
23. Abbas HA, Amini B, Wang WL, Ravi V. Maneuvering the Management of a Rare Case of Primary Undifferentiated Cardiac Sarcoma. Am J Case Rep 21:e918878, 2020. e-Pub 2020. PMID: 32198341.
24. Frezza AM, Assi T, Lo Vullo S, Ben-Ami E, Dufresne A, Yonemori K, Noguchi E, Siontis B, Ferraro R, Teterycz P, Duffaud F, Ravi V, Vincenzi B, Gelderblom H, Pantaleo MA, Baldi GG, Desar I, Fedenko A, Maki RG, Jones RL, Benjamin RS, Blay JY, Kawai A, Gounder M, Gronchi A, Le Cesne A, Mir O, Czarnecka AM, Schuetze S, Wagner AJ, Adam J, Barisella M, Sbaraglia M, Hornick JL, Meurgey A, Mariani L, Casali PG, Thornton K, Stacchiotti S. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network. Cancer 126(1):98-104, 2020. e-Pub 2019. PMID: 31536651.
25. Ali AMR, Tsai JW, Leung CH, Lin H, Ravi V, Conley AP, Lazar AJ, Wang WL, Nathenson MJ. The immune microenvironment of uterine adenosarcomas. Clin Sarcoma Res 10:5, 2020. e-Pub 2020. PMID: 32231779.
26. Parkes A, Urquiola E, Bhosale P, Lin H, Watson K, Wang WL, Feig B, Torres K, Roland CL, Conley AP, Zarzour M, Livingston JA, Ratan R, Ludwig J, Araujo DM, Ravi V, Benjamin RS, Patel S, Somaiah N. PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma. Sarcoma 2020:8363986, 2020. e-Pub 2020. PMID: 32565716.
27. Ravi V, Reardon MJ. Commentary: Primary cardiac sarcoma-Systemic disease requires systemic therapy. J Thorac Cardiovasc Surg. e-Pub 2019. PMID: 31780067.
28. Konduri V, Halpert MM, Baig YC, Coronado R, Rodgers JR, Levitt JM, Cerroni B, Piscoya S, Wilson N, DiBernardi L, Omarbekov Z, Seelhoff L, Ravi V, Douglass L, Decker WK. Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma. Cancer Gene Ther 26(9-10):282-291, 2019. e-Pub 2019. PMID: 30670791.
29. Roszik J, Khan A, Conley AP, Livingston JA, Groisberg R, Ravi V, Carmagnani Pestana R, Sen S, Subbiah V. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets. Cancers (Basel) 11(9), 2019. e-Pub 2019. PMID: 31480474.
30. Subbiah V, Anderson PM, Kairemo K, Hess K, Huh WW, Ravi V, Daw NC, Somaiah N, Ludwig JA, Benjamin RS, Chawla S, Hong DS, Meric-Bernstam F, Ravizzini G, Kleinerman E, Macapinlac H, Rohren E. Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial. Clin Cancer Res 25(13):3802-3810, 2019. e-Pub 2019. PMID: 30733229.
31. Conley AP, Wang WL, Livingston JA, Ravi V, Tsai JW, Ali A, Ingram DR, Lowery CD, Roland CL, Somaiah N, Hwu P, Yee C, Subbiah V, Futreal A, Lazar AJ, Patel S, Roszik J. MAGE-A3 is a clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31096717.
32. Ravi V, Leja M, Reardon MJ. A needle in a haystack. J Thorac Cardiovasc Surg 156(6):2204-2205, 2018. e-Pub 2018. PMID: 29908695.
33. Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK. Sorafenib for Advanced and Refractory Desmoid Tumors. N Engl J Med 379(25):2417-2428, 2018. PMID: 30575484.
34. Nathenson MJ, Conley AP, Lin H, Fleming N, Lazar A, Wang WL, Ravi V. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes. Int J Gynecol Cancer 28(7):1297-1310, 2018. PMID: 30044322.
35. Somaiah N, Beird HC, Barbo A, Song J, Mills Shaw KR, Wang WL, Eterovic K, Chen K, Lazar A, Conley AP, Ravi V, Hwu P, Futreal A, Simon G, Meric-Bernstam F, Hong D. Targeted next generation sequencing of well-differentiated/dedifferentiated liposarcoma reveals novel gene amplifications and mutations. Oncotarget 9(28):19891-19899, 2018. e-Pub 2018. PMID: 29731991.
36. Khan JA, Maki RG, Ravi V. Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment. J Clin Oncol 36(2):JCO2017749812, 2018. e-Pub 2017. PMID: 29220293.
37. Bui N, Kamat N, Ravi V, Chawla S, Lohman M, Ganjoo KN. A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma. Rare Tumors 10:2036361318771771, 2018. e-Pub 2018. PMID: 29760870.
38. Yanagawa B, Mazine A, Chan EY, Barker CM, Gritti M, Reul RM, Ravi V, Ibarra S, Shapira OM, Cusimano RJ, Reardon MJ. Surgery for Tumors of the Heart. Semin Thorac Cardiovasc Surg 30(4):385-397, 2018. e-Pub 2018. PMID: 30205144.
39. Dembla V, Groisberg R, Hess K, Fu S, Wheler J, Hong DS, Janku F, Zinner R, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Herzog CE, Karp DD, Roszik J, Meric-Bernstam F, Subbiah V. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Sci Rep 7(1):15963, 2017. e-Pub 2017. PMID: 29162825.
40. Wagner MJ, Gopalakrishnan V, Ravi V, Livingston JA, Conley AP, Araujo D, Somaiah N, Zarzour MA, Ratan R, Wang WL, Patel SR, Lazar A, Ludwig JA, Benjamin RS. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults. Oncologist 22(10):1271-1277, 2017. e-Pub 2017. PMID: 28710342.
41. Ikoma N, Torres KE, Lin HY, Ravi V, Roland CL, Mann GN, Hunt KK, Cormier JN, Feig BW. Recurrence Patterns of Retroperitoneal Leiomyosarcoma and Impact of Salvage Surgery. J Surg Oncol 116(3):313-319, 2017. e-Pub 2017. PMID: 28557016.
42. Francis AM, Alexander A, Liu Y, Vijayaraghavan S, Low KH, Yang D, Bui T, Somaiah N, Ravi V, Keyomarsi K, Hunt KK. CDK4/6 inhibitors sensitize Rb-positive sarcoma cells to Wee1 kinase inhibition through reversible cell cycle arrest. Mol Cancer Ther 16(9):1751-1764, 2017. e-Pub 2017. PMID: 28619757.
43. Leon-Castillo A, Chrisinger JSA, Panse G, Samdani RT, Ingram DR, Ravi V, Prieto VG, Wang WL, Lazar AJ. Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series. J Cutan Pathol 44(8):692-697, 2017. e-Pub 2017. PMID: 28556023.
44. Schvartsman G, Wagner MJ, Amini B, Zobniw CM, Trinh VA, Barbo AG, Lin HY, Wang WL, Conley AP, Ravi V, Araujo DM, Zarzour MA, Benjamin RS, Patel S, Somaiah N. Treatment patterns, efficacy and toxicity of regorafenib in gastrointestinal stromal tumour patients. Sci Rep 7(1):9519, 2017. e-Pub 2017. PMID: 28842575.
45. Abu Saleh WK, Ramlawi B, Shapira OM, Al Jabbari O, Ravi V, Benjamin R, Durand JB, Leja MJ, Blackmon SH, Bruckner BA, Reardon MJ. Improved Outcomes With the Evolution of a Neoadjuvant Chemotherapy Approach to Right Heart Sarcoma. Ann Thorac Surg 104(1):90-96, 2017. e-Pub 2017. PMID: 28189277.
46. Groisberg R, Hong DS, Holla V, Janku F, Piha-Paul S, Ravi V, Benjamin R, Kumar Patel S, Somaiah N, Conley A, Ali SM, Schrock AB, Ross JS, Stephens PJ, Miller VA, Sen S, Herzog C, Meric-Bernstam F, Subbiah V. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget 8(24):39254-39267, 2017. e-Pub 2017. PMID: 28424409.
47. Wagner MJ, Ravi V, Menter DG, Sood AK. Endothelial cell malignancies: new insights from the laboratory and clinic. NPJ Precis Oncol 1(1):11, 2017. e-Pub 2017. PMID: 29872699.
48. Roszik J, Wang WL, Livingston JA, Roland CL, Ravi V, Yee C, Hwu P, Futreal A, Lazar AJ, Patel SR, Conley AP. Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes. Clin Sarcoma Res 7:11, 2017. e-Pub 2017. PMID: 28630682.
49. Satcher RL, Ravi V, Wang WL, Oates S. Postpartum Treatment of Metastatic Recurrent Giant Cell Tumor of Capitate Bone of Wrist. Am J Orthop (Belle Mead NJ) 46(4):E269-E275, 2017. PMID: 28856360.
50. Quintana RA, Banchs J, Gupta R, Lin HY, Raj SD, Conley A, Ravi V, Araujo D, Benjamin RS, Patel S, Vadhan-Raj S, Somaiah N. Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion. Sarcoma 2017:7495914, 2017. e-Pub 2017. PMID: 29081684.
51. Nathenson MJ, Conley AP, Lin H, Fleming N, Ravi V. Treatment of Recurrent or Metastatic Uterine Adenosarcoma. Sarcoma 2017:4680273, 2017. e-Pub 2017. PMID: 29445312.
52. Nathenson MJ, Ravi V, Fleming N, Wang WL, Conley A. Uterine Adenosarcoma: a Review. Curr Oncol Rep 18(11):68, 2016. PMID: 27718181.
53. Subbiah V, Hess KR, Khawaja MR, Wagner MJ, Tang C, Naing A, Fu S, Janku F, Piha-Paul S, Tsimberidou AM, Herzog CE, Ludwig JA, Patel S, Ravi V, Benjamin RS, Meric-Bernstam F, Hong DS. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep 6:35448, 2016. e-Pub 2016. PMID: 27748430.
54. Ravi V, Sanford EM, Wang WL, Ross JS, Ramesh N, Futreal A, Patel S, Stephens PJ, Miller VA, Ali SM. Antitumor Response of VEGFR2- and VEGFR3-Amplified Angiosarcoma to Pazopanib. J Natl Compr Canc Netw 14(5):499-502, 2016. PMID: 27160228.
55. Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KE. Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg 151(4):1-8, 2016. e-Pub 2015. PMID: 26629783.
56. Ramlawi B, Leja MJ, Abu Saleh WK, Al Jabbari O, Benjamin R, Ravi V, Shapira OM, Blackmon SH, Bruckner BA, Reardon MJ. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience. Ann Thorac Surg 101(2):698-702, 2016. e-Pub 2015. PMID: 26476808.
57. Kamali F, Wang WL, Guadagnolo BA, Fox PS, Lewis VO, Lazar AJ, Conley AP, Ravi V, Toliyat M, Ladha HS, Hobbs BP, Amini B. MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumors. Br J Radiol 89(1058):20150308, 2016. e-Pub 2015. PMID: 26577289.
58. Gupta R, Heshami N, Jay C, Ramesh N, Song J, Lei X, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Predictors of survival in patients with sarcoma admitted to the intensive care unit. Clin Sarcoma Res 6:12, 2016. e-Pub 2016. PMID: 27437097.
59. Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KE. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol 22(12):3913-20, 2015. e-Pub 2015. PMID: 25743327.
60. Meric-Bernstam F, Brusco L, Shaw K, Horombe C, Kopetz S, Davies MA, Routbort M, Piha-Paul SA, Janku F, Ueno N, Hong D, De Groot J, Ravi V, Li Y, Luthra R, Patel K, Broaddus R, Mendelsohn J, Mills GB. Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol 33(25):2753-62, 2015. e-Pub 2015. PMID: 26014291.
61. Chen K, Meric-Bernstam F, Zhao H, Zhang Q, Ezzeddine N, Tang LY, Qi Y, Mao Y, Chen T, Chong Z, Zhou W, Zheng X, Johnson A, Aldape KD, Routbort MJ, Luthra R, Kopetz S, Davies MA, de Groot J, Moulder S, Vinod R, Farhangfar CJ, Shaw KM, Mendelsohn J, Mills GB, Eterovic AK. Clinical Actionability Enhanced through Deep Targeted Sequencing of Solid Tumors. Clin Chem 61(3):544-53, 2015. e-Pub 2015. PMID: 25626406.
62. Ravi V, Patel S, Benjamin RS. Chemotherapy for soft-tissue sarcomas. Oncology (Williston Park) 29(1):43-50, 2015. PMID: 25592207.
63. Joseph J, Wang WL, Patnana M, Ramesh N, Benjamin R, Patel S, Ravi V. Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma. Clin Sarcoma Res 5:22, 2015. e-Pub 2015. PMID: 26500758.
64. Hampras SS, Moysich KB, Marimuthu SP, Ravi V, Jayaprakash V. Socioeconomic factors and the risk for sarcoma. Eur J Cancer Prev 23(6):560-5, 2014. e-Pub 2013. PMID: 24356343.
65. Ramlawi B, Al-Jabbari O, Blau LN, Davies MG, Bruckner BA, Blackmon SH, Ravi V, Benjamin R, Rodriguez L, Shapira OM, Reardon MJ. Autotransplantation for the resection of complex left heart tumors. Ann Thorac Surg 98(3):863-8, 2014. e-Pub 2014. PMID: 25086947.
66. Behjati S, Tarpey PS, Sheldon H, Martincorena I, Van Loo P, Gundem G, Wedge DC, Ramakrishna M, Cooke SL, Pillay N, Vollan HKM, Papaemmanuil E, Koss H, Bunney TD, Hardy C, Joseph OR, Martin S, Mudie L, Butler A, Teague JW, Patil M, Steers G, Cao Y, Gumbs C, Ingram D, Lazar AJ, Little L, Mahadeshwar H, Protopopov A, Al Sannaa GA, Seth S, Song X, Tang J, Zhang J, Ravi V, Torres KE, Khatri B, Halai D, Roxanis I, Baumhoer D, Tirabosco R, Amary MF, Boshoff C, McDermott U, Katan M, Stratton MR, Futreal PA, Flanagan AM, Harris A, Campbell PJ. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet 46(4):376-9, 2014. e-Pub 2014. PMID: 24633157.
67. Reardon MJ, Ravi V. Invited commentary. Ann Thorac Surg 97(4):1385-6, 2014. PMID: 24694414.
68. Satelli A, Mitra A, Cutrera JJ, Devarie M, Xia X, Ingram DR, Dibra D, Somaiah N, Torres KE, Ravi V, Ludwig JA, Kleinerman ES, Li S. Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res 74(6):1645-50, 2014. e-Pub 2014. PMID: 24448245.
69. Chavez AL, Singh P, Aleman AA, Anderson JE, Jernigan C, Ravi V. Tools to expedite the development of treatment plans. Qual Manag Health Care 23(2):70-5, 2014. PMID: 24710182.
70. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL, Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma 2014:375151, 2014. e-Pub 2014. PMID: 25024639.
71. Hoffman A, Ghadimi MP, Demicco EG, Creighton CJ, Torres K, Colombo C, Peng T, Lusby K, Ingram D, Hornick JL, Wang WL, Ravi V, Lazar AJ, Lev D, Pollock RE. Localized and metastatic myxoid/round cell liposarcoma: Clinical and molecular observations. Cancer 119(10):1868-77, 2013. e-Pub 2013. PMID: 23401071.
72. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjamin RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clin Sarcoma Res 3(1):7, 2013. e-Pub 2013. PMID: 23663788.
73. Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, Pollock RE. Long-Term Outcomes in Patients with Radiation-Associated Angiosarcomas of the Breast Following Surgery and Radiotherapy for Breast Cancer. Ann Surg Oncol 20(4):1267-74, 2013. e-Pub 2012. PMID: 23224828.
74. Yadav BS, Bansal A, Sharma SC, Javid SH, Anderson BO, Vaklavas C, Forero A, Ravi V, Patel S, Boudadi K, Chugh R, Morris GJ. A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer. Semin Oncol 40(2):135-44, 2013. PMID: 23540738.
75. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 2012. PMID: 23272660.
76. Raj SD, Zhou X, Bueso-Ramos CE, Ravi V, Patel S, Benjamin RS, Vadhan-Raj S. Prognostic Significance of Elevated D-Dimer for Survival in Patients with Sarcoma. Am J Clin Oncol 35(5):462-7, 2012. e-Pub 2011. PMID: 21654313.
77. Ravi V, Patel S. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am 21(2):243-53, 2012. e-Pub 2012. PMID: 22365517.
78. Yusuf SW, Bathina JD, Qureshi S, Kaynak HE, Banchs J, Trent JC, Ravi V, Daher IN, Swafford J. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes. Heart Int 7(1):e4, 2012. e-Pub 2012. PMID: 22690297.
79. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WL, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clin Sarcoma Res 2(2):2, 2012. e-Pub 2012. PMID: 22587772.
80. Epner DE, Ravi V, Baile WF. When patients and families feel abandoned. Support Care Cancer 19(11):1713-7, 2011. e-Pub 2010. PMID: 20853170.
81. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol 23(4):361-366, 2011. PMID: 21577109.
82. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck 33(5):661-7, 2011. e-Pub 2010. PMID: 20960566.
83. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 22(4):351-5, 2010. PMID: 20485168.
84. Pandurengan RK, Dumont AG, Araujo DM, Ludwig JA, Ravi V, Patel S, Garber J, Benjamin RS, Strom SS, Trent JC. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol. e-Pub 2010. PMID: 20348145.
85. Ravi V, Benjamin RS. Systemic therapy for cardiac sarcomas. Methodist Debakey Cardiovasc J 6(3):57-60, 2010. PMID: 20834213.
86. Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev D. Outcome of Locally Recurrent and Metastatic Angiosarcoma. Ann Surg Oncol 16(9):2502-9, 2009. e-Pub 2009. PMID: 19551444.
87. Ravi V, Wong MK. Strategies and Methodologies for Identifying Molecular Targets in Sarcomas and Other Tumors. Current Treatment Options in Oncology 6(6):487-97, 2005.
88. Ravi V, Hyland A, Cummings KM, Mahoney M.. Associations Between Cancer Rates and Risk Factors by Region in New York State 1991-1994. Journal of Cancer Education Suppl to Vol 15(3):39, 2000.
89. Alexa Bello, Mir B. Alikhan, Aparna Subramaniam, Zenab I. Yusuf, Bruce Brockstein, Vinod Ravi. Adult-onset multifocal kaposiform hemangioendothelioma in the bone marrow, lung, liver, and brain: a case report. Frontiers in Oncology.

Abstracts

1. Rutkowski P, Gelderblom H, Blay JV, Wagner AJ, vandeSande M, Gonzalez AF, Stacchiotti S, Cesne AL, Alcindor T, Serrano C, Palmerini E, Ravi V, Herraez AC, Seddon B. Efficacy and safety of tenosynovial giant cell tumour (TGCT): Phase 2 expansion. 2022 ESMO Meeting, 2022.
2. Somaiah N, Livingston JA, Ravi V, Lin HY, Amini B, Luisa Maren Solis, Conley AP, Zarzour MA, Ludwig JA, Ratan R, Wang WL, Araujo DM, Patel SR, Roland CL, Lazar AJ, Gorlick RG, Parra ER, Haymaker CL. A phase II multi-arm study to test the efficacy of oleclumab and durvalumab in specific sarcoma subtypes. 2022 Annual ASCO Meeting, 2022.
3. Thirasastr P, Joseph C, Araujo DM, Benjamin RS, Conley AP, Livingston JA, Ludwig JA, Patel SR, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Outcomes in late-line systemic treatment in GISTs: Does sequence matter?. 2022 Annual ASCO Meeting, 2022.
4. Dickson MA, Ravi V, Riedel RF, Ganjoo KN, Van Tine VA, Chug R, Cranmer LD, Gordon EM, Chen JL, Murphy MC, Schmid AN, Desai N, Palma NA, Kwaitkowski DJ, Wagner AJ. nab-Sirolimus for patients with advanced malignant with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program. 2022 ASCO Annual Meeting, 2022.
5. Wagner AJ, Ravi V, Riedel, RF, Ganjoo KN, Van Tine A, Rashmi Chugh ; Lee D. Cranmer ; Erlinda M. Gordon ; Jason L. Hornick ; Heng Du ; Berta Grigorian; Anita N. Schmid; Shihe Hou; Katherine Harris; David J. Kwiatkowski; Neil P. Desai; Mark A. Dickson. Final Analysis From Ampect, An Open-Label Phase 2 Registration Trial Of Nab-Sirolimus For Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (Pecoma). 2021 Annual CTOS Virtual Meeting, 2021.
6. Dickson MA, Ravi V, Chen JL, Murphy MC, Thomas CY, Schmid AN, Wagner AJ. Nab-Sirolimus In Patients With Malignant Pecoma Previously Treated With Mtor Inhibitors: Emerging Experience From An Expanded Access Program. 2021 CTOS Annual Virtual Meeting, 2021.
7. Moyers JY, Roszik J, Pestana C, Livingston JA, Zarzour A, Ravi V, Ratan R, Somaiah N, Conley AP, Subbiah V. Examining Stripes On A Herd Of Zebras: Impact Of Genomic Matching For Ultrarare Sarcomas In Phase 1 Clinical Trials. 2021 CTOS Annual Virtual Meeting, 2021.
8. Thirasastr P, Behrang Amini, Heather Lin, Christina L. Roland, Elise F. Nassif, Alejandra Zarzour, Anthony P. Conley, Dejka M. Araujo, Emily Z. Keung, J Andrew Livingston, Ravin Ratan, Joseph A. Ludwig, IV, Robert S Benjamin, Xiao Zhou, Shreyaskumar Patel, Vinod Ravi, Barry W. Feig, Neeta Somaiah. Retrospective Evaluation Of The Role Of Gemcitabine- Docetaxel In Well-Differentiated And Dedifferentiated Liposarcoma. 2021 CTOS Annual Virtual Meeting, 2021.
9. Roberto Carmagnani Pestana, Justin Moyers, Nelson Hamerschlak, Jason Roszik, Shiraj Sen, David S. Hong, Aung Naing, Cynthia Herzog, Siqing Fu, Vinod Ravi, Shreyaskumar Patel, J Andrew Livingston, Neeta Somaiah, Anthony P. Conley, Funda Meric-Bernstam, Vivek Subbiah. Precision Oncology In Sarcoma Drug Development: Impact Of Biomarker Matching On Outcomes In Phase I Clinical Trials. 2021 CTOS Annual Virtual Meeting, 2021.
10. Dickson MA, Ravi V, Ganjoo KN, Iyer G. Institutional experience with nab-sirolimus in patients with malignancies harboring TSC1 or TSC2 mutations. 2021 ASCO Annual Virtual Meeting, 2021.
11. Williams LA, Whisenant M, Mendoza TR, Malveaux D, Griffin D, Ponce D, Cleeland CS, Peek A, Granwehr BP, Hutcheson KA, Shaw KR, Ravi V, Woodman SE, Chung C, Aloia TA, Futreal PA, Jaffray DA, Subbiah IM. Development and validation of a novel patient-reported outcomes (PRO) measure for symptom burden in patients with cancer and COVID-19 infection. 2021 ASCO Annual Virtual Meeting, 2021.
12. Ishwaria Mohan Subbiah, Loretta A. Williams, Angela Peek, Sanjay Shete, Bruno Palma Granwehr, David D'Achiardi, Anastasia Turin, Elizabeth A. Garcia, Janice Finder, Roy Chemaly, Kimberly Beltran, Kenna Rael Shaw, Meagan Whisenant, Scott Eric Woodman, Vinod Ravi, Hussein Abdul-Hassan Tawbi, Vivek Subbiah, Caroline Chung, Phillip Andrew Futreal, David A Jaffray. Real-world patient-reported and clinical outcomes of BNT162b2 mRNA COVID-19 vaccine in patients with cancer. 2021 ASCO Annual Virtual Meeting, 2021.
13. Akash Mitra, Neeta Somaiah, Anthony P. Conley, Behrang Amini, Heather Lin, Beatriz E. Sanchez, Celia Garcia-Prieto, Grace Mathew, Chantale Bernatchez, Vinod Ravi, Dejka Araujo, Maria A. Zarzour, John A. Livingston, Christina L. Roland, Najat Daw, Joshua Baguley, Wei-Lien Wang, Hannah Beird, Taylor Tate, Cara Haymaker, Latasha D. Little, Curtis Gumbs, Xingshi Song, Emily Z. Keung, Shaojun Zhang, Swati Gite, Jianhua Zhang, Luisa Solis, Hussein Tawbi, Linghua Wang, Shreyaskumar Patel, Robert S. Benjamin, Alexander J. Lazar, Ignacio I. Wistuba, Andrew Futreal. Immunogenomic correlates of response to combination immune checkpoint blockade in advanced sarcoma. 2021 AACR Annual Meeting, 2021.
14. Subramaniam A, Zheng J, Yalamanchili S, Conley AP, Ratan R, Somaiah N, Livingston JA, Zarzour MA, Araujo DM, Benjamin RS, Patel SR, Ravi V. Modulation of YAP/TAZ by Statins to Improve Survival in Epitheloid Hemangioendothelioma (EHE). 2020 Annual ASCO Virtual Meeting, 2020.
15. Somaiah N, Conley AP, Lin H, Amini B, Sabir SH, Araujo DM, Benjamin RS, Livingston JA, Patel SR, Ravin R, Ravi V, Zarzour MA, Wang WL, Tate T, Roland CL, Daw N, Futreal A, Wistuba I,. A Phase II Multi-Arm Study of Durvalumab and Tremelimumab for Advanced or Metastic Sarcomas. 2020 Annual ASCO Virtual Meeting, 2020.
16. Wagner AJ, Ravi V, Riedel RF, Ganjoo K, Van Tine BA, Chugh R, Cranmer LD, Gordon EM, Hornick JL, Du H, Grigorian B, Schmid AN, Hou S, Harris K, Kwaitkowski D, Desai N, Dickson M.. Long-Term Follow-Up From Ampect, An Open-Label Phase 2 Registration Trial Of Nab-Sirolimus For Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (Pecoma). CTOS 2020 Virtual Annual Meeting, 2020.
17. Alfaro-Munoz K, Hallatt G, Sookprasong J, Yu E, Jin J, Futreal A, deGroot JF. Accelerating neuro-oncology research and improving patient care through a robust data foundation. Society for Neuro-Oncology Annual Scientific Meeting, 2019.
18. Vinod Ravi, Andrew Scott Brohl, Sant P. Chawla, Steven Attia, Richard F. Riedel, David A. Liebner, Katherine Anne Thornton, Atrayee Basu Mallick, Cyrus R. Mehta, Lingyun Liu, Delia Alvarez, Charles P. Theuer, Steven Ian Robinson, Nicolas Penel, Silvia Stacchiotti, William D. Tap, Robin Lewis Jones, Robert G. Maki. TAPPAS: An adaptive enrichment phase 3 trial of TRC105 and pazopanib versus pazopanib alone in patients with advanced angiosarcoma. The American Society of Clinical Oncology Annual Meeting, 2018.
19. Dineen SP, Watson K, Al Sannaa G, May C, Ingram D, Wang W, Lazar A, Ravi V, Hunt K, Cormier J, Feig B. Variations in Protein Expression are associated with Survival Outcomes in Patients with Undifferentiated Pleomorphic Sarcomas, 2014.
20. Feig B, Hunt K, Cormier J, Roland C, Giacco G, Madewell J, Benjamin R, Ravi V. Is F-18 fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET/CT) of value in soft tissue sarcoma management?", 2014.
21. Vinod Ravi, Naveen Ramesh, Madhavi Patnana, Anthony P Conley, Neeta Somaiah, Maria A Zarzour, Davis Ingram, Latasha Little, , Alexei Protopopov, Alexander J Lazar, Jianhua Zhang, Dejka Araujo, Keila E Torres, Siraj Ali, Vincent A Miller, Philip J Stephens, Robert S. Benjamin, Patrick Hwu, Shreyaskumar Patel, Andrew Futreal.. Whole Exome and Targeted Sequencing of Angiosarcomas: Target identification and treatment implications. ASCO 2014 Annual Meeting, 2014.
22. Rohan Gupta DO1; Naveen Ramesh2; Rose Jean Erfe8; Kristen Carter PA3; Dejka Araujo, MD6; Robert Benjamin, MD4; Shreyaskumar Patel, MD5; Joseph Nates MD7; Vinod Ravi MD9*. Survival and Outcomes of sarcoma patients admitted to the intensive care unit at MD Anderson. ASCO 2014 Annual Meeting, 2014.
23. Chavez AL, Singh P, Aleman A, Anderson J, Jernigan C, Ravi V. Improvement of time to develop treatment plan at a specialized sarcoma center. Journal of Clinical Oncology (Meeting Abstracts) 30(suppl 34), 2012.
24. Ravi V, Gupta R, Demicco EG, Araujo DM, Ludwig JA, Benjamin RS, Wang WL, Patel SR. Atypical vascular neoplasms and risk of development of angiosarcoma. Journal of Clinical Oncology, 2012 ASCO Annual Meeting Proceedings 30(No. 15S):Abstract 10071, 2012.
25. Ravi V, Wang WL, Taylor SH, Patel SR, Baker L, Benjamin RS. Long-Term Outcomes of Metastatic Sarcoma: Is Metastatic Sarcoma Curable?. 17th Annual Connective Tissue Oncology Meeting, 2012.
26. Hoffman AL, Ghadimi MP, Demicco EG, Creighton CJ, Torres KE, Colombo C, Peng T, Ingram D, Hornic JL, Wang WL, Nielsen TO, Ravi V, Lazar AJ, Lev D, Pollock RE. Localized an Metastatic Myxoid/Round Cell Liposarcoma: Clinical and Molecular Observations. 17TH Annual Connectve Tissue Oncology Society Meeting, 2012.
27. Conley A, Reynoso D, Yoo Y, Bloom G, Wang W, Dumont A, Dumont S, Gonzalez R, Reed D, Ravi V, Wang J, Pledger W, Zhang W, Trent JC. MicroRNA Expression Characteristics in Imatinib-Treated, Paired GIST Samples - a Correlative Study of ID03-0023. CTOS Annual Meeting, 2011.
28. Park MS, Patel SR, Ravi V, Conley AP, Trent JC, Lazar AJF, Lev D, Wang X, Benjamin RS, Araujo DM. The role of chemotherapy in advanced hemangiopericyoma/solitary fibrous tumor. Journal of Clinical Oncology, 2011 ASCO Annual Meeting Proceedings 29, No. 15(Abstract 10097), 2011.
29. Ravi V, Yang J, Araujo DM, Park MS, Benjamin RS, Zhang W, Trent JC, Patel SR. The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy. Journal of Clinical Oncology, 2011 ASCO Annual Meeting Proceedings 29(No 15_suppl):Abstract 10096, 2011.
30. Wang W, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent J, Patel SR, Lewis VO, Lin P, Pollock RE, Guadagnolo A, Zagars G, Benjamin RS, Madewell JE, Lazar AJ. Extensive fatty maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosamide and pre-operative radiation therapy, 2010.
31. Ravi V, Wang W, Araujo DM, Ludwig JA, Luke RJ, Lewis VO, Trent JC, Benjamin RS, Patel SR. Imatinib in the treatment of tenosynovial giant-cell tumor and pigmented villonodular synovitis. Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings 28(No 15_suppl):Abstract 10011, 2010.
32. Katz D, Boonsirikamchai P, Benjamin RS, Patel S, Ludwig JA, Trent JC, Xiao L, Ravi V, Choi H, Araujo DM. Efficacy of neoadjuvant doxorubicin and ifosfamide (AI) in myxoid/round cell liposarcoma (MRCL): The MD Anderson Cancer Center experience (MDACC). Journal of Clinical Oncology, 2010 ASCO Annual Meeting Proceedings 28(15_suppl):Abstract 10080, 2010.
33. S. Stacchiotti; R. Benjamin; J.Y. Blay; I. Judson; A. Le Cesne; R. Maki; E. Palassini; S. Patel; P. Rutkowski; I. Ray-Coquard; M. Scurr; J. Trent; V. Ravi; P.G. Casali. Sunitinib In Advanced Alevolar Soft Part Sarcoma (ASPS): A Multi-Institutional Retrospective Case Series Analysis Within the World Sarcoma Network. 2010 CTOS Annual Meeting(Abstract 893840), 2010.
34. Conley AP, Araujo DM, Ludwig JA, Ravi V, Samuels BL, Choi H, Thall PF, Patel SR, Benjamin R, Trent J. A randomized phase II study of perifosine (P) plus imatinib for patients with imatinib-resistant gastrointestinal stromal tumor (GIST). Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings 27(No 15S):Abstract 10563, 2009.
35. Nolden LK, Shum L, Dumont A, Patel S, Araujo DM, Ludwig JA, Ravi V, George S, Vadhan- Raj S, Benjamin RS, Trent JC. Steady-State Plasma Imatinib Levels In 124 GIST Patients: Distribution, Dose, Dose Escalation, and Response. 2009 CTOS Annual Meeting(39288), 2009.
36. Sakharpe AK, Lahat G, Rao P, Ravi V, Hornick J, Lazar AJ, Lev D. Clinical and Molecular Insights Into Epithelioid Sarcoma. 2009 CTOS ANNUAL MEETING(39268), 2009.
37. Ravi V, Henry D, Dim DC, Chen S, Aggarwal, Hicks Dg, Cheney RT, Wong MK. Chemoresistant Malignant Human Endothelial Cells Overexpress Angiogenesis and Apoptosis Genes. AACR Annual Meeting, 2007.
38. Ravi V, Kim S, Dim D, Hicks D, Aggarwal C, Hostetter G, Cheney RT, M. Bittner, Trump DL, Wong MK. Identification of therapeutic targets in angiosarcoma. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings 25(No. 18S):Abstract 10030, 2007.
39. Dim D, Ravi V, Tan J, Hicks D, Wong M. The actin-bundling motility protein fascin and vascular endothelial growth factor (VEGF) are universally over-expressed in human angiosarcoma. Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings 25(No. 18S):Abstract 10068, 2007.
40. Ravi V, Henry D, Chen S, Wong MK. The mechanism of human angiosarcoma drug resistance. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings 24(No. 18S):Abstract 9567, 2006.

Book Chapters

1. Livingston JA, Conley AP, Ravi V, Patel SR. Chapter 42: Soft tissue and bone sarcomas. In: The MD Anderson Manual of Medical Oncology, 3rd edition. McGraw HIll, 2022.
2. Subramanian A, Giani C, Napolitano A, Ravi V, Freeza AM, Jones RL. Management of Vascular Sarcoma. In: Surgical Oncology Clinics of North America. Elsevier, 485-510, 2022.
3. Benjamin RS, Wagner MJ, Livingston JA, Ravi V, Patel SR. Chemotherapy for bone sarcomas in adults: the MD anderson experience. In: Am Soc Clin Oncol Educ Book, e656-60, 2015.
4. Marcus M. Monroe, MD, Beverly A. Guadagnolo, MD, MPH, Vinod Ravi, MD, Wei-Lien Wang, MD, and Erich M. Sturgis, MD, MPH. Chapter 27: Sarcomas and Soft Tissue Tumors of the Head and Neck. In: Myers & Hanna, 2014.
5. Ravi V, Patel S. Vascular Sarcomas. In: Curr Oncol Rep. 4. MD Anderson Cancer Center: Houston, Texas, 347-55, 2013.
6. Ravi V, Patel S.. Desmoid Tumors: Systemic Therapy. In: UPTODATE: Waltham, MA, 2010.
7. Raut CP, Ravi V, Patel S, DeLaney TF. Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapy-II. In: UPTODATE. Basow, DS: Waltham, MA, 2010.